Government of Liberia Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2015
NCT02363322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ministry of Health, Liberia | The Ministry of Health and Social Welfare of the Republic of Liberia

Active Ingredients

Drugs in Phase 2 Trials (2)

simeprevir (olysio) (1 trial)

zmapp (1 trial)

Drugs in Other Trials (3)

folic acid (1 trial)

iron (1 trial)

mebendazole (vermox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Hemorrhagic Fever, Ebola (Phase 2)

Infections (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5